Jump Financial, LLC Crinetics Pharmaceuticals, Inc. Transaction History

Jump Financial, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Oct 21, 2024	SELL	$25.62 - $37.07 $522,468 - $755,968	-20,393 Reduced 42.95%	27,083 $963,000
Q4 2023 Feb 07, 2024	SELL	$25.62 - $37.07 $522,468 - $755,968	-20,393 Reduced 42.95%	27,083 $963,000
Q3 2023 Oct 21, 2024	BUY	$15.97 - $30.59 $758,191 - $1.45 Million	47,476 New	47,476 $1.41 Million
Q3 2023 Nov 07, 2023	BUY	$15.97 - $30.59 $758,191 - $1.45 Million	47,476 New	47,476 $1.41 Million
Q3 2022 Nov 07, 2022	BUY	$18.11 - $22.37 $516,135 - $637,545	28,500 New	28,500 $560,000

241

79.5M

23.3K

44.3K

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $2.9B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.